Journals / Turkish Journal of Plastic Surgery / 2016 / Cilt: 24 - Sayı: 2

Linear Cutaneous Atrophy Development Due to Intralesional Corticosteroid Therapy: Case Report and Review of the Literature

İntralezyoner Kortikosteroid Tedavisi Sonrası Gelişen Lineer Kutanöz Atrofi: Olgu Sunumu ve Literatürün Gözden Geçirilmesi

Pages
90–93
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, pathogenesis of rarely developing linear skin atrophy induced by intralesional corticosteroid administration during scar treatment, clinical and treatment outcomes were presented in the light of the literature

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Intralesional corticosteroid administration is a procedure involving the injection of a steroid solution into abnormal skin, especially with scars and/or keloids.
📊
Key Findings & Data:After the application of topical corticosteroids, atrophy may rarely develop in the skin and subcutaneous tissue.
💡
Conclusion & Impact:In this study, pathogenesis of rarely developing linear skin atrophy induced by intralesional corticosteroid administration during scar treatment, clinical and treatment outcomes were presented in the light of the literature
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Intralesional corticosteroid administration is a procedure involving the injection of a steroid solution into abnormal skin, especially with scars and/or keloids. After the application of topical corticosteroids, atrophy may rarely develop in the skin and subcutaneous tissue. When the developed atrophy of the skin becomes permanent, aesthetic problems that lead to psychological problems negatively affect the daily life of the patients. In this study, pathogenesis of rarely developing linear skin atrophy induced by intralesional corticosteroid administration during scar treatment, clinical and treatment outcomes were presented in the light of the literature

Özet

İntralezyoner kortikosteroid uygulaması, özellikle skar ve keloid tedavisinde sıkça kullanılmaktadır. Lokal kortikosteroid uygulamaları sonrasında nadir olarak deri ve derialtı dokularda atrofi gelişebilmektedir. Ciltte oluşan atrofi, kalıcı hale geldiğinde, estetik problemlere eşlik eden psikolojik problemlere yol açmakta ve hastaların günlük yaşamına negatif yönde etki etmektedir. Bu çalışmada, skar tedavisinde kullanılan intralezyoner kortikosteroide bağlı nadir olarak gelişen cilt atrofisinin etyopatogenezi, klinik bulguları ve tedavi sonuçları literatür bilgileri eşliğinde sunuldu

🔖

Cite This Article

DURMUŞ, M., YAPICI, A. K., ESKİ, M., ÖZTÜRK, S. (2016). Linear Cutaneous Atrophy Development Due to Intralesional Corticosteroid Therapy: Case Report and Review of the Literature. Turkish Journal of Plastic Surgery, Cilt: 24 - Sayı: 2, 90–93. https://ajindex.com/articles/375896

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Firooz A, Tehranchi-Nia Z, Ahmed AR. Benefits andrisks of intralesional corticosteroid injection in the treatment of dermatological diseases. Clin Exp Dermatol 1995
  2. 20(5): 363-70. [CrossRef] 2. Jang WS, Park J, Yoo KH, Han TY, Li K, Seo SJ, Hong CK. Branch-shaped cutaneous hypopigmentation and atrophyafter ıntralesional triamcinolone injection. Ann Dermatol 2011
  3. 23(1): 111-4. [CrossRef] 3. Cantürk F, Cantürk T, Aydin F, Karagöz F, Sentürk N, Turanli AY. Cutaneous linearatrophy followingin tralesional corticosteroid injection in the treatment of tendonitis. Cutis 2004
  4. 73(3): 197-8. 4. Nanda V, Parwaz MA, Handa S. Linear hypopigmentation after triamcinolone injection: a rare complication of a common procedure. Aesthetic Plast Surg 2006
  5. 30(1): 118-9. [CrossRef] 5. George WM. Linear lymphatic hypopigmentation after intralesional corticosteroid injection: report of two cases. Cutis 1999
  6. 64(1): 61-4. 6. Suzuki S, Sirado M. A case of localized involutional lipoatrophy. Keisei Geka 2004
  7. André P. Post-cortisone lipo-atrophy treated by an autologous graft of adipose cell islets. Ann Dermatol Venereol 1990
  8. 117(10): 733-4. 8. Latoni JD, Marshall DM, Wolfe SA. Overgrowth of fat autotransplanted for correction of localized steroid-induced atrophy. Plast Reconstr Surg 2000
  9. 106(7): 1566-9. [CrossRef] 9. Neuber F. Fett transplantation. Chir Kongr Verhandl Deutch Gesellsch Chir 1893
  10. Bircoll M. Cosmetic breast augmentation utilizing autologous fat and liposuction techniques. Plast Reconstr Surg 1987
  11. 79(2): 267-71. [CrossRef] 11. Johnson GW. Body contouring by macroinjection of autologous fat. Am J Cosmet Surg 1987
  12. Illouz YG. Present results of fat injection. Aesthetic Plast Surg 1988
  13. 12(3): 175-81. [CrossRef] 13. Coleman SR. Structural fat grafting: more than a permanent filler. Plast Reconstr Surg 2006
  14. 118(Suppl 3): 108S-120S. 14. Schoepe S, Schäcke H, May E, Asadullah K. Glucocorticoid therapy- induced skin atrophy. Exp Dermatol 2006
  15. 15(6): 406-20. [CrossRef] 15. Kikuchi I, Horikawa S. Letter: Perilymphaticatrophy of the skin. Arch Dermatol 1975
  16. 111(6): 795-6. [CrossRef] 16. Imagawa K, Ohkuma S. A case of fat injection for treating subcutaneous atrophy caused by local administration of corticosteroid. Tokai J Exp Clin Med 2010
  17. 35(2): 66-9. 17. Friedman SJ, Butler DF, Pittelkow MR. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroidtherapy. Report of two cases and review of the lite